» Articles » PMID: 38073952

Amiodarone and Adenosine for Pediatric Supraventricular Tachycardia: A Systematic Review

Overview
Journal Cureus
Date 2023 Dec 11
PMID 38073952
Authors
Affiliations
Soon will be listed here.
Abstract

A review of the literature was made to find and choose research papers, on drugs (amiodarone and adenosine) used for managing supraventricular tachycardia (SVT) in children and infants (one hour to 17 years of age) with no structural heart disease by PRISMA guideline. Our team conducted an exhaustive systematic literature review (SLR), utilizing an extensive search methodology across recognized databases like PubMed, PubMed Central, Google Scholar, Web of Science, and The Cochrane Library. We included 10 scholarly articles that satisfied our rigorous selection criteria including systematic reviews/meta-analysis, and randomized control trials, shedding light on treatment with amiodarone and adenosine for SVT in pediatric patients. There is no first- or second-line treatment for SVT in pediatrics, and drug effectiveness can vary significantly between patients. Adenosine has a shorter half-life than other drugs, instead, it is safer and more valuable when an electrocardiogram is uncertain, it is recommended as an acute management, and it continues as the first-line option for paroxysmal SVT. Amiodarone management patients with acute STV within, its use showed better results when administered 48 hours after diagnosis. Furthermore, it is recommended to reduce the incidence of junctional ectopic tachycardia (JET), by pre-operative prophylaxis, also for chronic control in this and other types of SVT. In none of the evaluated studies were documented significant adverse effects in pediatric patients. Side effects that did occur were mild and easily managed. The studies also emphasize that although both amiodarone and adenosine can successfully convert SVT to sinus rhythm, better results have been observed when using combined therapies of each recommended medication. Therefore, more randomized clinical trials, meta-analyses, and systematic reviews are needed to solidify and possibly standardize an effective and safe pharmacological treatment for SVT and its types in pediatric patients.

Citing Articles

Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED).

Michel-Behnke I, Muller M, Stiller B, Kriebel T, Kanaan M, Kornyei L Europace. 2025; 27(2).

PMID: 39947241 PMC: 11879349. DOI: 10.1093/europace/euaf025.

References
1.
Lei L, Chew D, Lee W, Meng Z, Ilhan E, Furlan R . Pharmacological Cardioversion of Atrial Tachyarrhythmias Using Single High-Dose Oral Amiodarone: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2021; 14(12):e010321. PMC: 8887812. DOI: 10.1161/CIRCEP.121.010321. View

2.
Wadile S, Sivakumar K, Murmu U, Ganesan S, Dhandayuthapani G, Agarwal R . Randomized controlled trial to evaluate the effect of prophylactic amiodarone versus dexmedetomidine on reducing the incidence of postoperative junctional ectopic tachycardia after pediatric open heart surgery. Ann Pediatr Cardiol. 2023; 16(1):4-10. PMC: 10243657. DOI: 10.4103/apc.apc_150_22. View

3.
El Amrousy D, Elshehaby W, El Feky W, Elshmaa N . Safety and Efficacy of Prophylactic Amiodarone in Preventing Early Junctional Ectopic Tachycardia (JET) in Children After Cardiac Surgery and Determination of Its Risk Factor. Pediatr Cardiol. 2016; 37(4):734-9. DOI: 10.1007/s00246-016-1343-5. View

4.
Ahmad F, Abu Sneineh M, Patel R, Rohit Reddy S, Llukmani A, Hashim A . In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia. Cureus. 2021; 13(6):e15502. PMC: 8261787. DOI: 10.7759/cureus.15502. View

5.
Hill A, Silka M, Bar-Cohen Y . A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Pacing Clin Electrophysiol. 2019; 42(6):670-677. DOI: 10.1111/pace.13662. View